Contract 75A50123C00068
Indivior Inc. · Department Of Health And Human Services · September 27, 2023
Indivior Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 27, 2023 for $52.27 million of work in pharmaceutical preparation manufacturing. Performance is in North Chesterfield, VA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses cost-plus contract pricing. The most recent modification was on August 19, 2025. If all options are exercised, the contract could reach $113.80 million.
Contract details
- PIID
- 75A50123C00068
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- North Chesterfield, VA
- First action
- September 27, 2023
- Latest action
- August 19, 2025
Description
INTRANASAL NALMEFENE DRUG DEVICE COMBINATION PRODUCT
Modification timeline
-
August 19, 2025Mod P00004 · Exercise An Option$52.90M
-
September 13, 2024Mod P00002 · Change Order$43.57M
-
August 22, 2024Mod P00001 · Exercise An Option$41.08M
-
September 27, 2023Base award$32.38M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123C00068?
Contract 75A50123C00068 is a federal contract awarded to Indivior Inc. by Department Of Health And Human Services on September 27, 2023 for $52.27 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 75A50123C00068?
Indivior Inc. won contract 75A50123C00068 from Department Of Health And Human Services.
How much is contract 75A50123C00068 worth?
Contract 75A50123C00068 has obligated $52.27 million to date, with a total potential value of $113.80 million if all options are exercised.